CORRIGENDUM: Unexplored therapeutic opportunities in the human genome (Nature Reviews Drug Discovery (2018) (10.1038/nrd.2018.14))

Tudor I. Oprea, Cristian G. Bologa, Søren Brunak, Allen Campbell, Gregory N. Gan, Anna Gaulton, Shawn M. Gomez, Rajarshi Guha, Anne Hersey, Jayme Holmes, Ajit Jadhav, Lars Juhl Jensen, Gary L. Johnson, Anneli Karlson, Andrew R. Leach, Avi Ma’ayan, Anna Malovannaya, Subramani Mani, Steven L. Mathias, Michael T. McManusTerrence F. Meehan, Christian von Mering, Daniel Muthas, Dac Trung Nguyen, John P. Overington, George Papadatos, Jun Qin, Christian Reich, Bryan L. Roth, Stephan C. Schürer, Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, Dušica Vidovic´, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi

Research output: Contribution to journalComment/debate

35 Scopus citations


In the version of this article that was originally published online, an older version of the data set categorizing proteins into target development levels was used to create Figure 1 than the version used to create Table 1, and data from Figure 1 were referred to at several points in the text of the article. Figure 1 and the associated text have been updated to match Table 1 in the online and print versions of the article. The authors apologize for any inconvenience that this error may have caused.

Original languageEnglish
Pages (from-to)377
Number of pages1
JournalNature Reviews Drug Discovery
Issue number5
StatePublished - 2018


Dive into the research topics of 'CORRIGENDUM: Unexplored therapeutic opportunities in the human genome (Nature Reviews Drug Discovery (2018) (10.1038/nrd.2018.14))'. Together they form a unique fingerprint.

Cite this